Company Analysis

STAAR Surgical Company (STAA)

Nasdaq: STAA · Ophthalmic Goods · Monrovia, CA · filing with the SEC since 1995
Grade3.4
◀ Past 3.5● Present 3.5▶ Future 3.0
1 est.

Who runs STAAR Surgical Company

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Foust Warren
President and CEO. First filing Mar 2023, latest Aug 18, 2026, 0 filings in all.
Officers reporting now
4
of 12 people with a filing in the last fifteen months
Directors reporting now
8
32 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Foust WarrenPresident and CEOMar 2023Aug 18, 2026none
Andrews Deborah JChief Financial Officer & EVPFeb 2006Aug 18, 2026none
Michna MagdaChief Development OfficerMar 2023Aug 18, 2026none
Sisitsky NathanielChief Legal OfficerDec 2023Dec 12, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Wang Christopher Min FangdirectorFeb 2026Jun 23, 2026none
Bradsher Neal CdirectorJun 2007Jun 22, 2026none
Butcher Arthur CdirectorMar 2024Jun 22, 2026none
Jiang WeidirectorMar 2024Jun 22, 2026none
Lebuhn Richard T.directorJan 2026Jun 22, 2026none
Silverman LoudirectorSep 2014Jun 22, 2026none
Zhou Lilian YanshengdirectorDec 2023Jun 22, 2026none
Broadwood Partners LPdirectorJun 2007Mar 13, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Broadwood Capital Inc10% ownerJun 2007Mar 13, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton STAA · research, not advice